From October 30, 2023 to December 31, 2023, the company has repurchased 506,300 shares, representing 0.25% for CNY 20.02 million. With this, the company has completed the repurchase of 506,300 shares, representing 0.25% for CNY 20.02 million under the buyback announced on October 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.33 CNY | +1.52% | +0.45% | -20.22% |
05-20 | PharmaBlock Sciences, Inc. Approves Cash Dividend for the Year 2023 | CI |
04-24 | PharmaBlock Proposes Final Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.22% | 860M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 300725 Stock
- News PharmaBlock Sciences (Nanjing), Inc.
- Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.